Ares Financial Consulting »

Jade Biosciences shares owned by Ares Financial Consulting

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Ares Financial Consulting from 13F filings

Historical chart of Ares Financial Consulting investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Ares Financial Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Ares Financial Consulting

Quarter filed Position value Share count Share price at filing
2026-06-30 $444 20 22.20

More positions owned by Ares Financial Consulting

Vanguard Total Stock Market Etf Etf (VTI)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Dimensional U.s. Targeted Value Etf Etf (DFAT)
Nvidia Corporation Stock (NVDA)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Dimensional International Core Equity Market Etf Etf (DFAI)
Avantis U.s. Equity Etf Etf (AVUS)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)
Pimco 15 Year Us Tips Index Exchange-traded Fund Etf (LTPZ)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Apple Stock (AAPL)
Vanguard Total International Stock Etf Etf (VXUS)
Saba Closed End Funds Etf Etf (CEFS)
Dimensional International Core Equity 2 Etf Etf (DFIC)

View all positions for Ares Financial Consulting

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
RA Capital Management
Bellevue Group
VR Adviser
Henderson Group
BlackRock
Vanguard Capital Management
Baker Bros. Advisors
Remedium Capital Partners
Versant Venture Management
Avidity Partners Management
Samsara BioCapital
Dr. Jeffrey R. Jay, M.D.
Marshall Wace

View all funds holding Jade Biosciences